CV Sciences, Inc. (CVSI) stock
CVSIOTCPharmaceutical PreparationsFiscal year ends December 31
$0.01−0.00 (-21.13%)
Close on Oct 19, 2026Market cap $2.53MP/E –Yield –
CV Sciences enterprise value
Enterprise value is market cap plus debt, minus cash: the value of the whole business to all its investors.
CV Sciences's enterprise value was $2.14M on Oct 19, 2026, against $6.06M a year earlier. Over the last 5 years it ranged from $1.24M to $18.13M, with a median of $6.04M.
Enterprise Value at the end of each year
| Period | Period end | Value | Change |
|---|---|---|---|
| 2026 | Oct 19, 2026 | $2.14M | -82.0% |
| 2025 | Dec 31, 2025 | $11.89M | +126.5% |
| 2024 | Dec 31, 2024 | $5.25M | +15.6% |
| 2023 | Dec 29, 2023 | $4.54M | +35.0% |
| 2022 | Dec 30, 2022 | $3.36M | -70.8% |
| 2021 | Dec 31, 2021 | $11.53M | -73.8% |
| 2020 | Dec 31, 2020 | $43.99M | -46.4% |
| 2019 | Dec 31, 2019 | $82.07M | -79.3% |
| 2018 | Dec 31, 2018 | $395.66M | +644.9% |
| 2017 | Dec 29, 2017 | $53.12M | +145.3% |
| 2016 | Dec 30, 2016 | $21.66M | +196.4% |
| 2015 | Dec 31, 2015 | $7.31M | -90.0% |
| 2014 | Dec 31, 2014 | $73.38M | -78.1% |
| 2013 | Dec 31, 2013 | $334.47M | – |
See a number that looks wrong?